Literature DB >> 11339481

Reduced leukocyte adhesiveness in response to viral versus nonviral infection/inflammation.

M Kassirer1, D Zeltser, N Maharshak, R Rotstein, O Rogowsky, I Shapira, N Arber, A S Berliner.   

Abstract

BACKGROUND: Viral infection differs from nonviral infection/inflammation by not producing a significant acute phase response. Since inflammation can cause increased adhesiveness of peripheral white blood cells (WBC), we compared these adhesive properties in individuals with viral infection to those with nonviral infection/inflammation. PATIENTS AND METHODS: The state of leukocyte adhesiveness/aggregation in the peripheral blood of patients with viral versus nonviral infection/inflammation was examined in 101 consecutive patients with acute febrile disease.
RESULTS: A significant difference was found between the two groups; 13.6 +/- 7% for viral infection versus 22.8 +/- 8.5% for nonviral infection/inflammation (p < 0.0001). There was also a significant difference in the concentration of fibrinogen (361 +/- 109 mg/dl vs 554 +/- 172 mg/dl, p < 0.0001), and in the CD11b/CD18 cell surface expression (175 +/- 66 vs 210 +/- 100 in peripheral blood polymorphonuclear leukocytes).
CONCLUSION: The results of this study could explain, at least in part, the differential adhesive behavior of the WBC in the peripheral blood in the two populations.

Entities:  

Mesh:

Year:  2001        PMID: 11339481     DOI: 10.1007/s15010-001-9127-z

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  1 in total

1.  Superiority of a functional leukocyte adhesiveness/aggregation test over the white blood cell count to discriminate between mild and significant inflammatory response in patients with acute bacterial infections.

Authors:  Ori Rogowski; Rivka Rotstein; David Zeltzer; Sarit Misgav; Daniel Justo; Daniel Avitzour; Tamar Mardi; Jacob Serov; Nadir Arber; Shlomo Berliner; Itzhak Shapira
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.